Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema

Eye

Volumn 22, Issue 2, 2008, Pages 219-222

  Konstantopoulos, A ^a   Williams, C P R ^a   Luff, A J ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TOPICAL AGENT; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CASE STUDY; CATARACT EXTRACTION; CLINICAL ARTICLE; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PHACOEMULSIFICATION; POSTOPERATIVE CARE; RETINA MACULA CYSTOID EDEMA; RETINA TEAR; RETROSPECTIVE STUDY; TREATMENT RESPONSE; VISUAL ACUITY; VITRECTOMY; VITREOUS DISEASE;

EID: 39449098992     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702582     Document Type: Article

References (22)

1. Suckling RD, Maslin KF. Pseudophakic cystoid macular oedema and its treatment with local steroids. Aust NZ J Ophthalmol 1988; 16 353-359.
2. Weisz JM, Bressler NM, Bressler SB, Schachat AP. Ketorolac treatment of pseudophakic cystoid macular oedema identified more than 24 months after cataract extraction. Ophthalmology 1999; 106: 1656-1659.
3. Cox SN, Hay E, Bird AC. Treatment of chronic macular oedema with acetazolamide. Arch Ophthalmol 1988; 106: 1190-1195.
4. Lardenoye CWTA, van Schooneveld MJ, Treffers WF, Rothona A. Grid laser photocoagulation for macular oedema in uveitis or the Irvine-Gass syndrome. Br J Ophthalmol 1998; 82: 1013-1016.
5. Ip MS, Gottlieb JL, Kahana A, Scott IU, Altaweel MM, Blodi RA et al Intravitreal triamcinolone for treatment of macular oedema associated with central retinal vein occlusion. Arch Ophthalmol 2004; 122: 1131-1136.
6. Kok H, Lau C, Maycock N, McCluskey P, Lightman S. Outcome of intravitreal triamcinolone in uveitis. Ophthalmology 2005; 112 1916-1921.
7. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular oedema. Arch Ophthalmol 2003; 121: 57-61.
8. Benhamou N, Massin P, Haouchine B, Audren F, Tadayoni R, Gaudric A. Intravitreal triamcinolone for refractory pseudophakic macular oedema. Am J Ophthalmol 2003; 135: 246-249.
9. Karacorlu M, Ozdemir H, Karacorlu S. Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema. Acta Ophthalmol Scand 2003; 81: 648-652.
10. Jonas JB, Kreissig J, Degenring RF. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular oedema. Am J Ophthalmol 2003; 136: 384-386.
11. Boscia F, Furino C, Dammacco R, Ferreri P, Sborgia L, Sborgia C. Intravitreal triamcinolone acetonide in refractory pseudophakic cystoid macular oedema: Functional and anatomic results. Eur J Ophthalmol 2005; 15: 89-95.
12. Conway MD, Canakis C, Livir-Rallatos C, Peyman GA. Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular oedema. J Cataract Refract Surg 2003; 29: 27-33.
13. Gass JD, Anderson DR, Davis EB. A clinical, fluorescein angiographic and electron microscopic correlation of cystoid macular oedema. Am J Ophthalmol 1985; 100: 82-86.
14. Flach AJ, Stegman RC, Graham J, Kruger LP. Prophylaxis of aphakic cystoid macular oedema without corticosteroids: A paired-comparison, placebo-controlled, double-masked study. Ophthalmology 1990; 97 1253-1258.
15. Solomon LD. Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular oedema: Flurbiprofen-CME Study Group I. J Cataract Refract Surg 1995; 21: 73-81.
16. Flach AJ, Jampol LM, Weinberg D, Kraff MC, Yannuzzi LA et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular oedema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol 1991; 112: 514-519.
17. Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT, de Juan E Jr. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992; 110: 1155-1159.
18. Brooks Jr HL, Caballero Jr S, Newell CK, Steinmetz RL, Watson D, Segal MS et al. Vitreous levels of Vascular Endothelial Growth Factor and Stromal-Derived Factor 1 in patients with diabetic retinopathy and cystoid macular oedema before and after intraocular injection of triamcinolone. Arch Ophthalmol 2004; 122: 1801-1808.
19. Negi AK, Vernon SA, Lim CS, Owen-Armstrong K. Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation. Eye 2005; 19: 747-751.
20. Guex-Crosier Y. The pathogenesis and clinical presentation of macular oedema in inflammatory diseases. Doc Ophthalmol 1999; 97: 297-309.
21. Ozkiris A, Erkilic K. Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol 2005; 40: 63-68.
22. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003; 87: 24-27.